GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹9,295 Cr | ₹7,428 Cr | ₹8,424 Cr | ₹8,282 Cr | ₹7,360 Cr |
What is the latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹9,295 Cr |
| Mar2024 | ₹7,428 Cr |
| Mar2023 | ₹8,424 Cr |
| Mar2022 | ₹8,282 Cr |
| Mar2021 | ₹7,360 Cr |
How is Total Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,295 Cr | 25.14 | |
| Mar2024 | ₹7,428 Cr | -11.82 | |
| Mar2023 | ₹8,424 Cr | 1.71 | |
| Mar2022 | ₹8,282 Cr | 12.54 | |
| Mar2021 | ₹7,360 Cr | - | |
Compare Total Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹57,453.1 Cr | 0.8% | 4.9% | 28% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 0.8% |
4.9% |
28% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses